“
Although formulas have greatly improved over the years, no formula can fully replicate the immunological benefits of mother’s milk. In the summer of 2018, the administration of President Donald Trump provoked dismay among many health authorities by opposing an international resolution to encourage breast-feeding and reportedly threatened Ecuador, the sponsor of the initiative, with trade sanctions if it didn’t change its position. Cynics pointed out that the infant formula industry, which is worth $70 billion a year, might have had a hand in determining the U.S. position. A Department of Health and Human Services spokesperson denied that that was the case and said that America was merely “fighting to protect women’s abilities to make the best choices for the nutrition of their babies” and to make sure that they were not denied access to formula—something the resolution wouldn’t have done anyway.
”
”